The Need for Patient-Generated Health Data in Cancer Care. Growing interest in PGHD in oncology both reflects and reinforces an increasing role for patient advocates in directing regulatory priorities. 5 In 2009 the U.S. FDA released a draft guidance document encouraging patient-focused drug development to ensure that the patient experience is sufficiently represented in benefit-risk ....